Virtus ETF Advisers’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-18,823
| Closed | -$988K | – | 371 |
|
|
2020
Q3 | $988K | Buy |
18,823
+1,585
| +9% | +$65.6K | 0.52% | 76 |
|
|
2020
Q2 | $574K | Sell |
17,238
-17,954
| -51% | -$572K | 0.27% | 127 |
|
|
2020
Q1 | $957K | Sell |
35,192
-2,970
| -8% | -$82.7K | 0.39% | 115 |
|
|
2019
Q4 | $753K | Sell |
38,162
-19,687
| -34% | -$315K | 0.12% | 153 |
|
|
2019
Q3 | $750K | Sell |
57,849
-9,721
| -14% | -$117K | 0.15% | 157 |
|
|
2019
Q2 | $841K | Sell |
67,570
-1,745
| -3% | -$23.2K | 0.18% | 172 |
|
|
2019
Q1 | $1.01M | Buy |
69,315
+16,033
| +30% | +$205K | 2.14% | 6 |
|
|
2018
Q4 | $588K | Buy |
53,282
+19,249
| +57% | +$268K | 0.1% | 49 |
|
|
2018
Q3 | $895K | Buy |
34,033
+2,293
| +7% | +$62K | 0.09% | 57 |
|
|
2018
Q2 | $649K | Sell |
31,740
-36,744
| -54% | -$788K | 0.57% | 121 |
|
|
2018
Q1 | $1.24M | Sell |
68,484
-4,063
| -6% | -$67.7K | 1.08% | 16 |
|
|
2017
Q4 | $1.01M | Buy |
72,547
+8,058
| +12% | +$109K | 1.27% | 16 |
|
|
2017
Q3 | $1.19M | Hold |
64,489
| – | – | 0.16% | 52 |
|
|
2017
Q2 | $1.09M | Sell |
64,489
-8,171
| -11% | -$124K | 0.16% | 53 |
|
|
2017
Q1 | $970K | Buy |
72,660
+6,987
| +11% | +$109K | 0.17% | 70 |
|
|
2016
Q4 | $988K | Buy |
65,673
+10,580
| +19% | +$140K | 0.3% | 50 |
|
|
2016
Q3 | $644K | Buy |
55,093
+6,942
| +14% | +$81.6K | 0.31% | 57 |
|
|
2016
Q2 | $520K | Buy |
48,151
+10,869
| +29% | +$112K | 0.39% | 52 |
|
|
2016
Q1 | $344K | Buy |
+37,282
| New | +$401K | 0.47% | 57 |
|
Virtus ETF Advisers's MNTA Position: Q4 2020 in Review
Virtus ETF Advisers sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 18,823 shares — an estimated $988K sold.
Virtus ETF Advisers first reported a position in MNTA in Q1 2016 and held it in 19 quarters. The position peaked at $1.24M in Q1 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Virtus ETF Advisers reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Virtus ETF Advisers sold 18,823 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $988K.
- Virtus ETF Advisers first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2016 and held it in 19 quarters.
- Virtus ETF Advisers's Momenta Pharmaceuticals, Inc. position peaked at $1.24M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Virtus ETF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.